
Monoallergen Sublingual Immunotherapy Versus Multiallergen Subcutaneous Immunotherapy for Allergic Respiratory Diseases: A Debate During the AAAAI 2013 Annual Meeting in San Antonio, Texas
Keywords: کارآزمایی بالینی تصادفیسازی شده; AA; Allergic asthma; AIT; Allergen immunotherapy; AR; Allergic rhinitis; DBPC; Double-blind, placebo-controlled; FDA; US Food and Drug Administration; HDM; House dust mite; IR; Index of reactivity; RCT; Randomized clinical trial; SCIT; Subcutaneous allerg